Product Program year 2024 Source: CMS Open Payments

CardioFlux

Device Cardiovascular Diagnostic

Open in the dashboard

General payments

$62,178

26 payments

Research payments

$324,698

57 payments

Through program year 2024, $62,178 in general payments and $324,698 in research payments were reported against CardioFlux (Cardiovascular Diagnostic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $17,500 13
2024 Research $239,238 43
2023 General $44,678 13
2023 Research $85,460 14

Breakdown

Who paid General payments · program years 2023–2024
  1. Genetesis, Inc. $62,178 26 payments
Top recipients General payments · program year 2024
  1. Mazen Awais Cardiovascular Disease · Grove City, OH $16,500 94% · 12 payments
  2. The Christ Hospital Teaching hospital · OH $1,000 6% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Cardiovascular Disease Internal Medicine $16,500 100% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Ohio $17,500 100% · 2 recipients

Each share is of general payments naming this product in 2024 where a state was reported.

26 general · 57 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record